1. Home
  2. ARQT vs AAP Comparison

ARQT vs AAP Comparison

Compare ARQT & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • AAP
  • Stock Information
  • Founded
  • ARQT 2016
  • AAP 1929
  • Country
  • ARQT United States
  • AAP United States
  • Employees
  • ARQT N/A
  • AAP N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • AAP Auto & Home Supply Stores
  • Sector
  • ARQT Health Care
  • AAP Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • AAP Nasdaq
  • Market Cap
  • ARQT 3.3B
  • AAP 3.3B
  • IPO Year
  • ARQT 2020
  • AAP N/A
  • Fundamental
  • Price
  • ARQT $28.01
  • AAP $49.93
  • Analyst Decision
  • ARQT Strong Buy
  • AAP Hold
  • Analyst Count
  • ARQT 7
  • AAP 20
  • Target Price
  • ARQT $22.17
  • AAP $52.28
  • AVG Volume (30 Days)
  • ARQT 3.1M
  • AAP 1.8M
  • Earning Date
  • ARQT 10-28-2025
  • AAP 10-30-2025
  • Dividend Yield
  • ARQT N/A
  • AAP 2.00%
  • EPS Growth
  • ARQT N/A
  • AAP N/A
  • EPS
  • ARQT N/A
  • AAP N/A
  • Revenue
  • ARQT $317,929,000.00
  • AAP $8,624,327,000.00
  • Revenue This Year
  • ARQT $85.27
  • AAP N/A
  • Revenue Next Year
  • ARQT $30.70
  • AAP $0.89
  • P/E Ratio
  • ARQT N/A
  • AAP N/A
  • Revenue Growth
  • ARQT 129.21
  • AAP N/A
  • 52 Week Low
  • ARQT $9.19
  • AAP $28.89
  • 52 Week High
  • ARQT $28.96
  • AAP $70.00
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 71.06
  • AAP 45.41
  • Support Level
  • ARQT $22.26
  • AAP $48.08
  • Resistance Level
  • ARQT $24.39
  • AAP $52.17
  • Average True Range (ATR)
  • ARQT 1.46
  • AAP 2.47
  • MACD
  • ARQT 0.21
  • AAP 0.30
  • Stochastic Oscillator
  • ARQT 85.67
  • AAP 69.34

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About AAP Advance Auto Parts Inc.

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.

Share on Social Networks: